Fore Biotherapeutics at AACR 2027
Apr 2–7, 2027 Orlando, FL ~23k attendees Website
Fore Biotherapeutics at AACR 2027 in Orlando: Booth 2107.
| Organization | AACR 2027 Attendance |
|---|---|
Fore Biotherapeutics Philadelphia, PA | |
Clinical-stage company developing plixorafenib, a next-generation BRAF inhibitor that avoids paradoxical MAPK activation, in a phase 2 basket trial for BRAF-altered cancers. | Booth Exhibiting at Booth 2107 Sun, Apr 412:00pm–5:00pmMon, Apr 59:00am–5:00pmTue, Apr 69:00am–4:00pm |
Find decision makers at Fore Biotherapeutics
Tell us what you sell and we’ll find the people at Fore Biotherapeutics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the American Association for Cancer Research. Organization details are derived from AACR’s published exhibitor list. Submit a correction